CAS 99291-25-5|Levodropropizine

Introduction:Basic information about CAS 99291-25-5|Levodropropizine, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
Common NameLevodropropizine
CAS Number99291-25-5Molecular Weight236.310
Density1.2±0.1 g/cm3Boiling Point412.7±34.0 °C at 760 mmHg
Molecular FormulaC13H20N2O2Melting Point102-106ºC
MSDS/Flash Point220.9±24.3 °C

Names

Namelevodropropizine
SynonymMore Synonyms

Levodropropizine BiologicalActivity

DescriptionLevodropropizine (DF-526) is a histamine receptor inhibitor, Levodropropizine is an effective and very well tolerated peripheral antitussive drug.
Related CatalogSignaling Pathways >>GPCR/G Protein >>Histamine ReceptorSignaling Pathways >>Immunology/Inflammation >>Histamine ReceptorResearch Areas >>Inflammation/Immunology
References

[1]. Zanasi A, et al. Levodropropizine for treating cough in adult and children: a meta-analysis of published studies. Multidiscip Respir Med. 2015 May 31;10(1):19.

Chemical & Physical Properties

Density1.2±0.1 g/cm3
Boiling Point412.7±34.0 °C at 760 mmHg
Melting Point102-106ºC
Molecular FormulaC13H20N2O2
Molecular Weight236.310
Flash Point220.9±24.3 °C
Exact Mass236.152481
PSA46.94000
LogP0.46
Vapour Pressure0.0±1.0 mmHg at 25°C
Index of Refraction1.577
InChIKeyPTVWPYVOOKLBCG-ZDUSSCGKSA-N
SMILESOCC(O)CN1CCN(c2ccccc2)CC1
Storage conditionRefrigerator

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
TZ1075100
CHEMICAL NAME :
1,2-Propanediol, 3-(4-phenylpiperazin-1-yl)-, S(-)-
CAS REGISTRY NUMBER :
99291-25-5
LAST UPDATED :
199609
DATA ITEMS CITED :
5
MOLECULAR FORMULA :
C13-H20-N2-O2
MOLECULAR WEIGHT :
236.35

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
887 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity) Gastrointestinal - other changes
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 38,1150,1988
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
401 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 38,1150,1988
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1281 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity) Gastrointestinal - other changes
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 38,1150,1988
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
408 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 38,1150,1988
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - guinea pig
DOSE/DURATION :
2493 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity) Behavioral - convulsions or effect on seizure threshold Gastrointestinal - other changes
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 38,1150,1988

Safety Information

HS Code2933599090

Customs

HS Code2933599090
Summary2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Articles25

More Articles
Efficacy and tolerability of levodropropizine and dropropizine in children with non-productive cough.

J. Int. Med. Res. 23(3) , 175-83, (1995)

The antitussive efficacy and tolerability of dropropizine and of its enantiomer levodropropizine were evaluated in children with non-productive cough; 258 were evaluable for tolerability and 254 for e...

Efficacy of levodropropizine in pediatric cough.

Pulm. Pharmacol. Ther. 25(5) , 337-42, (2012)

Cough in children is among the most common problems managed by pediatricians, and occurs more frequently in preschool than in older children. Most acute episodes of cough are due to viral upper respir...

Studies on the human metabolism and the toxicologic detection of the cough suppressant dropropizine in urine using gas chromatography-mass spectrometry.

Ther. Drug Monit. 26(4) , 441-9, (2004)

Studies are described on the metabolism and the toxicologic analysis of the nonopioid cough suppressant dropropizine [R,S-3-(4-phenyl-1-piperazinyl)1,2-propandiol, DRO] in human urine using gas chroma...

Synonyms

(S)-dropropizine
Levdropropizina
1,2-Propanediol,3-(4-phenyl-1-piperazinyl)-,(R)
(-)-Dropropizine
rapitux
1,2-Propanediol, 3-(4-phenyl-1-piperazinyl)-, (2S)-
(+)-Dropropizine
(2S)-3-(4-phenylpiperazin-1-yl)propane-1,2-diol
(R)-3-(4-Phenylpiperazin-1-yl)propane-1,2-diol
Levdropropizina [Latin,Spanish]
(2S)-3-(4-Phenyl-1-piperazinyl)-1,2-propanediol
(R)-3-(4-Phenyl-1-piperazinyl)-1,2-propanediol
Levodropropizine
Dropropizine S-form
CAS 120014-06-4|donepezil
CAS 41294-56-8|Alfacalcidol
Recommended......
TOP